216 related articles for article (PubMed ID: 8907284)
1. The comparison of 2-chlorodeoxyadenosine (2-Cd A) in combination with interferon alpha (IFN alpha) or interferon gamma (IFN gamma) on granulocyte-macrophage progenitor cells (CFU-GM) and clonogenic blasts in (CFU-L) in vitro cultures.
Robak T; Korycka A
Leuk Lymphoma; 1996 Mar; 21(1-2):161-8. PubMed ID: 8907284
[TBL] [Abstract][Full Text] [Related]
2. Interaction of 2-chlorodeoxyadenosine in combination either with interferons or recombinant human tumor necrosis factor alpha on myeloid progenitor cells in vitro.
Korycka A; Robak T
Arch Immunol Ther Exp (Warsz); 1996; 44(4):259-64. PubMed ID: 9017167
[TBL] [Abstract][Full Text] [Related]
3. The interaction of 2-chlorodeoxyadenosine (2-CDA) and interferon alpha (IFN-alpha) on normal and myeloid leukemia hematopoiesis in vitro.
Robak T; Korycka A; Góra-Tybor J
Leuk Res; 1994 Apr; 18(4):275-81. PubMed ID: 7909573
[TBL] [Abstract][Full Text] [Related]
4. The influence of recombinant human tumor necrosis factor alpha and its muteins used alone or in combination with 2-chlorodeoxyadenosine on normal and leukemic hematopoiesis in vitro.
Korycka A; Robak T
Leuk Res; 1997 Sep; 21(9):857-65. PubMed ID: 9393601
[TBL] [Abstract][Full Text] [Related]
5. The effect of cyclosporin A used alone and in combination with either 2-chlorodeoxyadenosine or fludarabine on normal and chronic myelogenous leukemia progenitors in vitro.
Korycka A; Robak T
Arch Immunol Ther Exp (Warsz); 2003; 51(1):61-7. PubMed ID: 12691305
[TBL] [Abstract][Full Text] [Related]
6. The influence of imatinib mesylate (STI571) used alone or in combination with purine nucleoside analogues on the normal and chronic myelogenous leukaemia progenitor cells in vitro.
Korycka A; Robak T
Leuk Lymphoma; 2003 Sep; 44(9):1549-55. PubMed ID: 14565659
[TBL] [Abstract][Full Text] [Related]
7. The influence of amifostine used alone or in combination with 2-chlorodeoxyadenosine on normal and chronic myelogenous leukemia granulocyte-macrophage progenitor cells in vitro.
Korycka A; Robak T
Arch Immunol Ther Exp (Warsz); 2000; 48(4):293-9. PubMed ID: 11059647
[TBL] [Abstract][Full Text] [Related]
8. The influence of farnesyl protein transferase inhibitor R115777 (Zarnestra) alone and in combination with purine nucleoside analogs on acute myeloid leukemia progenitors in vitro.
Korycka A; Smolewski P; Robak T
Eur J Haematol; 2004 Dec; 73(6):418-26. PubMed ID: 15522064
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity on myeloid progenitors of a combination of 2-chloro-2'-deoxyadenosine and interferon alpha: the effects of IL-1 and GM-CSF.
Ballarino P; Castello G; Lerza R; Cerruti A; Bogliolo G; Pannacciulli I
Leuk Res; 1996 Sep; 20(9):777-80. PubMed ID: 8947588
[TBL] [Abstract][Full Text] [Related]
10. Treatment with interferon-alpha preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors (CFU-GM) from patients with chronic myeloid leukemia but spares normal CFU-GM.
Gordon MY; Marley SB; Lewis JL; Davidson RJ; Nguyen DX; Grand FH; Amos TA; Goldman JM
J Clin Invest; 1998 Aug; 102(4):710-5. PubMed ID: 9710439
[TBL] [Abstract][Full Text] [Related]
11. Synergistic antiproliferative effect of recombinant interferon-gamma with recombinant interferon-alpha on chronic myelogenous leukemia hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E, and CFU-GM).
Carlo-Stella C; Cazzola M; Ganser A; Bergamaschi G; Pedrazzoli P; Hoelzer D; Ascari E
Blood; 1988 Oct; 72(4):1293-9. PubMed ID: 3139105
[TBL] [Abstract][Full Text] [Related]
12. The tyrosine kinase inhibitor STI571, like interferon-alpha, preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors from patients with chronic myeloid leukemia.
Marley SB; Deininger MW; Davidson RJ; Goldman JM; Gordon MY
Exp Hematol; 2000 May; 28(5):551-7. PubMed ID: 10812245
[TBL] [Abstract][Full Text] [Related]
13. Influence of gemcitabine (2',2'-difluoro-deoxycytidine) and 2-chlorodeoxyadenosine on growth of normal and leukemic cells in vitro.
Lech-Marańda E; Korycka A; Robak T
Eur J Haematol; 2000 Nov; 65(5):317-21. PubMed ID: 11092462
[TBL] [Abstract][Full Text] [Related]
14. Combination of interferon alpha with either Ara-C or ATRA in vitro reduces the selective action of interferon against CML CFU-GM.
Marley SB; Davidson RJ; Goldman JM; Gordon MY
Leukemia; 2000 Aug; 14(8):1396-400. PubMed ID: 10942234
[TBL] [Abstract][Full Text] [Related]
15. The influence of recombinant human tumor necrosis factor (rh-TNF alpha) on granulocyte-macrophage progenitor cells (CFU-GM) and clonogenic leukaemic blasts (CFU-L) in cultures in vitro.
Robak T; Korycka A; Góra-Tybor J; Piotrowska-Wrzesień A; Krykowski E
Arch Immunol Ther Exp (Warsz); 1992; 40(5-6):339-43. PubMed ID: 1340192
[TBL] [Abstract][Full Text] [Related]
16. Combined effect of interferon-gamma and tumor necrosis factor-alpha causing suppression of leukemic blast progenitors in acute myeloblastic leukemia.
Nara N
Leuk Lymphoma; 1993 Jun; 10(3):201-7. PubMed ID: 7693101
[TBL] [Abstract][Full Text] [Related]
17. The effect of lithium chloride on granulocyte-macrophage progenitor cells (CFU-GM) and clonogenic leukaemic blasts (CFU-L) in the cultures in vitro.
Korycka A; Robak T
Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):495-500. PubMed ID: 1668709
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma enhances growth factor-dependent proliferation of clonogenic cells in acute myeloblastic leukemia.
Murohashi I; Hoang T
Blood; 1991 Aug; 78(4):1085-95. PubMed ID: 1714325
[TBL] [Abstract][Full Text] [Related]
19. A differential sensitivity to recombinant human interferon-alpha 2a between normal and chronic myeloid leukaemic peripheral blood granulocyte-macrophage colony-forming units.
Gronthos S; To LB; Haylock DN; Juttner CA
Leuk Res; 1992; 16(2):153-8. PubMed ID: 1545568
[TBL] [Abstract][Full Text] [Related]
20. Clonogenic assay is not predictive but reflects therapeutic efficacy of interferons in the treatment of chronic myelogenous leukemia.
Wandl UB; Niederle N; Kranzhoff M; Seeber S
Int J Cell Cloning; 1992 Sep; 10(5):292-8. PubMed ID: 1453016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
